Tratamiento farmacológico del paciente adulto con diagnóstico de esquizofrenia que presenta conducta violenta o agitación

Gómez-Restrepo, Carlos; Bohórquez Peñaranda, Adriana Patricia; Ávila, Mauricio J; Jaramillo González, Luis Eduardo; Vélez Fernández, Carolina; Vélez Traslaviña, Ángela; García Valencia, Jenny; Pinzón-Amado, Alexander.
Rev. colomb. psiquiatr ; 43(supl.1): 59-65, dic. 2014. ilus, tab
Artículo en Español | LILACS, COLNAL | ID: lil-784949

Documentos relacionados

  1. Use of a Novel Standardized Administration Protocol Reduces Agitation Pro Re Nata (PRN) Medication Requirements: The Birmingham Agitation Management (BAM) Initiative.
  2. A systematic review of the effects of psychiatric medications on social cognition.
  3. Analysis of the status of drug treatment in 746 inpatients with early-onset schizophrenia in China: a retrospective study.
  4. Tratamiento con antipsicóticos de mantenimiento del paciente adulto con diagnóstico de esquizofrenia
  5. Clinical practice guideline on pharmacological and psychological management of adult patients with schizophrenia spectrum disorders and a comorbid substance use.
  6. Preclinical validation of the micropipette-guided drug administration (MDA) method in the maternal immune activation model of neurodevelopmental disorders.
  7. Relationship between TNF-α levels and psychiatric symptoms in first-episode drug-naïve patients with schizophrenia before and after risperidone treatment and in chronic patients.
  8. Metabolomics-based understanding of the olanzapine-induced weight gain in female first-episode drug-naïve patients with schizophrenia.
  9. [Contain psychomotor agitation in somatic units : implementation of a protocol at the HUG].
  10. Tratamiento con antipsicóticos en la fase aguda del paciente adulto con diagnóstico de esquizofrenia